In women with Graves' disease, a lower level of thyroid-stimulating immunoglobulin (59.5%) predicts relapse risk, while in men, a higher level (66.5%) is needed to indicate similar risk, suggesting biological differences in how the disease behaves by sex.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis could determine whether sex-specific TSI cutoffs are reproducible across populations and whether they improve prediction accuracy in women compared to men.
Systematic review and meta-analysis of all studies reporting sex-stratified TSI cutoffs for Graves' relapse prediction, comparing sensitivity, specificity, and AUC between men and women across different assays and ethnic groups.
An RCT could test whether using sex-specific TSI cutoffs (59.5% for women, 66.5% for men) reduces relapse compared to a single universal cutoff.
Multicenter RCT of 500 adults with Graves' disease, randomized to relapse prediction using sex-specific TSI cutoffs (women: <59.5%, men: <66.5%) vs. universal cutoff (66.5%). Primary outcome: relapse rate at 2 years.
A prospective cohort could validate that women with TSI >59.5% have higher relapse risk than men with the same level, confirming the need for sex-specific thresholds.
Prospective cohort of 400 adults with Graves' disease (200 female, 200 male), with TSI measured at ATD discontinuation. Primary outcome: relapse at 2 years, with separate ROC analyses for each sex to determine optimal cutoffs.
A case-control study could compare TSI kinetics or immune profiles between women who relapsed at low TSI and men who relapsed at high TSI to identify biological drivers.
Case-control study of 80 women who relapsed with TSI 50–65% and 80 men who relapsed with TSI 65–80%, comparing serum estrogen, TSH receptor antibody affinity, and B-cell activation markers.
A cross-sectional study could compare mean TSI levels at discontinuation between men and women who later relapsed to assess whether the difference is consistent.
Cross-sectional analysis of TSI levels at ATD discontinuation in 150 women and 150 men with Graves' disease, comparing mean values between those who relapsed and those who did not, stratified by sex.